Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP502257.RAUy2XmtrCdoOY-iWwfzk9xC_Xe-eXHlFNoh-85Dz9JoA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP502257.RAUy2XmtrCdoOY-iWwfzk9xC_Xe-eXHlFNoh-85Dz9JoA130_assertion type Assertion NP502257.RAUy2XmtrCdoOY-iWwfzk9xC_Xe-eXHlFNoh-85Dz9JoA130_head.
- NP502257.RAUy2XmtrCdoOY-iWwfzk9xC_Xe-eXHlFNoh-85Dz9JoA130_assertion description "[We have established a genetically defined differentiation model in human leukemia K562 cells by conditional expression of the cyclin-dependent kinase (Cdk) inhibitor p27 (inducible by Zn(2+)) and Myc (activatable by 4-hydroxy-tamoxifen).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP502257.RAUy2XmtrCdoOY-iWwfzk9xC_Xe-eXHlFNoh-85Dz9JoA130_provenance.
- NP502257.RAUy2XmtrCdoOY-iWwfzk9xC_Xe-eXHlFNoh-85Dz9JoA130_assertion evidence source_evidence_literature NP502257.RAUy2XmtrCdoOY-iWwfzk9xC_Xe-eXHlFNoh-85Dz9JoA130_provenance.
- NP502257.RAUy2XmtrCdoOY-iWwfzk9xC_Xe-eXHlFNoh-85Dz9JoA130_assertion SIO_000772 18838534 NP502257.RAUy2XmtrCdoOY-iWwfzk9xC_Xe-eXHlFNoh-85Dz9JoA130_provenance.
- NP502257.RAUy2XmtrCdoOY-iWwfzk9xC_Xe-eXHlFNoh-85Dz9JoA130_assertion wasDerivedFrom befree-20140225 NP502257.RAUy2XmtrCdoOY-iWwfzk9xC_Xe-eXHlFNoh-85Dz9JoA130_provenance.
- NP502257.RAUy2XmtrCdoOY-iWwfzk9xC_Xe-eXHlFNoh-85Dz9JoA130_assertion wasGeneratedBy ECO_0000203 NP502257.RAUy2XmtrCdoOY-iWwfzk9xC_Xe-eXHlFNoh-85Dz9JoA130_provenance.